Halozyme Therapeutics HALO Effective Income Tax Rate Reconciliation, Percent

Effective Income Tax Rate Reconciliation, Percent at other companies

RBC BearingsRBC

22.1%—

McCormick & Company, IncorporatedMKC

21.4%+0.9pp

SBA CommunicationsSBAC

15.1%—

SyscoSYY

23.6%+0.3pp

General MillsGIS

20.2%+0.6pp

AccentureACN

24.2%+0.2pp

Other financials

Income statement

See full

Revenue$376.7M+42.2%

Gross profit$297.5M+37.4%

Operating income$184.5M+30.4%

Net income$150.0M+27.1%

EPS (diluted)$1.22+31.2%

Balance sheet

See full

Cash & equivalents$312.0M+76.9%

Total debt$2.2B+41.7%

Total equity$219.6M-54.5%

Total assets$2.7B+21.7%

Cash flow

See full

Operating cash flow$180.1M+16.8%

CapEx$3.7M+294%

Free cash flow$176.3M+15.0%

Valuation

See full

Market cap$8.13B-2.9%

Enterprise value$10B+3.0%

P/E13.4×-3.8×

P/S5.4×-2.3×

Profitability

See full

Gross margin82.8%-0.7pp

Operating margin59.3%+9.0pp

Net margin47.9%+6.5pp

FCF margin44.3%-1.5pp

Returns & leverage

See full

Return on equity124.5%+12.7pp

Debt / equity9.9×+6.7×

Current ratio2.8×-5.6×

Where this comes from

Reported directly by Halozyme Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateContinuingOperations.

The official record: Halozyme Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Halozyme Therapeutics's effective income tax rate reconciliation, percent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Halozyme Therapeutics's effective income tax rate reconciliation, percent?: Halozyme Therapeutics (HALO) reported effective income tax rate reconciliation, percent of $0.17 in Q1 2026.
How has Halozyme Therapeutics's effective income tax rate reconciliation, percent changed year-over-year?: Halozyme Therapeutics's effective income tax rate reconciliation, percent decreased by 6.1% year-over-year, from $0.18 to $0.17.